YNHFS_B$?[!P_|X]ZH6F[,DUH[P/=L
SYSTEM PROCESSING...
YNHFS_B$?[!P_|X]ZH6F[,DUH[P/=L
SYSTEM PROCESSING...
Posted: 2025-04-10 04:59:54 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-10 05:00:14 UTC
Verified By
Rollup News
This study reveals that activating pyruvate kinase M2 (PKM2) in CD8 T cells can reprogram mitochondrial function, boosting their effector capabilities and enhancing the effectiveness of anti-PD1 therapy.
PKM2 activation reprograms mitochondrial function in CD8 T cells
Enhanced effector functions of CD8 T cells
Improved efficacy of anti-PD1 therapy
Metabolic reprogramming as a strategy to improve cancer immunotherapy
Understanding the metabolic requirements of T cells for effective cancer immunotherapy
Identifying strategies to enhance T cell effector functions in the tumor microenvironment
Overcoming resistance to anti-PD1 therapy